Journal of General Practice Nursing (GPN) | September 2020

Back to journal

Thousands of missing prostate cancer diagnoses due to Covid-19 pandemic

Thousands of missing prostate cancer diagnoses due to Covid-19 pandemic
Editorial

Pages: 10 - 13

Article topics: Covid-19 pandemic, Prostate cancer

The impact of COVID-19 has been felt across the UK and continues to be so, even with lockdown measures lifted in many parts of the country. As a specialist nurse at Prostate Cancer UK, we provide information and support to thousands of men living with and concerned about prostate cancer. We have heard many stories of the amazing measures that have been put in place by healthcare professionals to ensure appropriate access to treatment has continued, and we have also been hearing about the difficult decisions men and their medical teams have had to make around changes or delays to treatment by weighing up the risk of Covid-19 infection and the risk of their disease progression.


References

NHS England (2020) NHS England Cancer Waiting Times Data. Available online: www.england.nhs.uk/statistics/statisticalwork- areas/cancer-waiting-times (accessed 10 September, 2020)

Public Health England (2016) Guidance: Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing. Available online: www. gov.uk/government/publications/prostate-cancer-risk-managementprogramme-psa-test-benefits-and-risks/prostate-cancer-risk-managementprogramme-pcrmp-benefits-and-risksof-psa-testing (accessed 10 September, 2020)


Back to journal
View PDF

Digital edition

View in JCN reader

If you would like to write for the Journal of General Practice Nursing, please contact Binkie:
binkie@jcn.co.uk